A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance

Table 1 Summary of quality control criteria utilized to ensure quality responses

Criteria	Respondent sample (N = 1,020)	%
Summary of excluded responses
Assigned same value to all health states	139	13.6
Valued non-CS CMV lower than CS-symptomatic CMV and CS-asymptomatic CMV	96	9.4
Completed the survey(s) faster than 10 min and 25 s	78	7.6
Total number of respondents excluded from analysis	282	27.6
Total number of respondents included in analysis	738	72.4

CMV cytomegalovirus, CS-asymptomatic CMV clinically significant and asymptomatic cytomegalovirus, CS-symptomatic CMV clinically significant and symptomatic cytomegalovirus, non-CS CMV non-clinically significant cytomegalovirus

ISSN: 1477-7525